Eyepoint Pharmaceuticals experiences a surge in international media coverage, with 25 mentions in recent reports, highlighting increased interest in the company.

Gavi’s recent board meeting reaffirmed commitment to respecting country sovereignty, addressing health system fragility, and strengthening health security worldwide.

Gavi commits to vaccinating 500 million additional children worldwide despite funding challenges, intensifying global immunization efforts.

Gavi has approved a $180 million fund to boost vaccine manufacturing capacity across Africa, aiming to improve local access and health resilience.

The NHS has confirmed a significant funding increase aimed at reducing waiting times and expanding mental health services across England.

CDC warns of unprecedented heat-related emergency department visits amid rising temperatures, highlighting urgent health risks and ongoing climate concerns.

A confirmed parasite outbreak is causing widespread explosive diarrhea in multiple US states, prompting health alerts and investigations.